Abstract:To the best of our knowledge, this is the first series reporting the use of MVP in neurovascular disease. Use of this device may be associated with shorter procedural times and cost savings in comparison with the use of microcoils for vessel occlusion. Our experience shows that MVP can have unique applications in neurovascular pathologies and it complements other occlusive devices.
“…It is possible to safely occlude the lingual arteries over a relatively long segment. Although recently introduced devices have been reported to facilitate safe vessel occlusion of human arteries over a short segment,24 25 the safety of deconstructive approaches in these circumstances has not been fully elucidated. A longer period of follow-up time after treatment may have resulted in improved occlusion scores, but this was not studied in this work.…”
Treatment failures following flow diversion of bifurcation aneurysms can be caused by persistent flow to the jailed branch. Branch occlusion combined with flow diversion may improve angiographic occlusion scores of a canine bifurcation aneurysm model.
“…It is possible to safely occlude the lingual arteries over a relatively long segment. Although recently introduced devices have been reported to facilitate safe vessel occlusion of human arteries over a short segment,24 25 the safety of deconstructive approaches in these circumstances has not been fully elucidated. A longer period of follow-up time after treatment may have resulted in improved occlusion scores, but this was not studied in this work.…”
Treatment failures following flow diversion of bifurcation aneurysms can be caused by persistent flow to the jailed branch. Branch occlusion combined with flow diversion may improve angiographic occlusion scores of a canine bifurcation aneurysm model.
“…An MVP has shown immediate and stable target vessel occlusion without complications [3]. A two center pilot study by Pellerin et al in 14 patients showed successful navigation, deployment, and occlusion of tortuous, and small 1-3 mm diameter vessels with only 1 MVP per target artery [5].…”
Section: Discussionmentioning
confidence: 98%
“…The operator can inject contrast through the catheter before detaching the plug with the device deployed and then resheath it for precision placement. The MVP device has demonstrated promise and efficacy in neurovascular disease [3].…”
“…The Medtronic Micro Vascular Plug™ (MVP) is an FDA approved and CE marked product. It has been used for vascular embolization in neuro‐interventional and other interventional radiology procedures, mostly in adults . Since the MVP is a large diameter vascular occlusion device that can be delivered through a microcatheter, it may be ideally suited for use in children with CHD.…”
Section: Introductionmentioning
confidence: 99%
“…It has been used for vascular embolization in neuro-interventional and other interventional radiology procedures, mostly in adults. [14][15][16][17][18] Since the MVP is a large diameter vascular occlusion device that can be delivered through a microcatheter, it may be ideally suited for use in children with CHD. The objective of this study was to describe the early, multi-center clinical experience with the MVP in children with underlying CHD undergoing vascular embolizations.…”
The MVP is a new, large-diameter vascular embolization device that can be delivered through a microcatheter. It may play an important role in providing highly effective occlusion of abnormal vessels in children.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.